ArticleCureus2026
Predictors of Survival Following Acute Nontraumatic Mesenteric Ischemia in North India: A Prospective Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAcute mesenteric ischemia (AMI) is a life-threatening and rare cause of abdominal pain. No single laboratory test or clinical finding helps diagnose or predict the prognosis of AMI.
aimThis study aimed to determine the morbidity and prognostic factors that affect the postoperative outcomes of patients undergoing surgery for bowel ischemia. METHODOLOGY: This prospective observational study was conducted between July 2019 and December 2020 in North India. The study included 40 patients undergoing surgery for bowel ischemia. Patients under 18 years of age and those with bowel ischemia following trauma were excluded.
resultsA total of 40 patients were treated, out of whom 15 (37.5%) survived. Overall mortality was 62.5% (25/40). The mean age of the study population was 56.18 years. Compared with survivors, arterial pH was significantly lower (7.36 vs. 7.40,
conclusionsAMI continues to carry a high risk of mortality, particularly in patients presenting late with extensive bowel involvement and systemic complications. The use of antiplatelet drugs is an effective way to prevent severe complications. Patient age, pH, LDH, CRP, serum lactate, remaining length of small bowel from DJ, and large bowel involvement are significant predictors of mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.